뒤로
Affymax Inc(AFFY) 가격
AFFY 주가 차트
AFFY 주가 예측
Affymax Inc
$0
0%
$0
종가: Jan 26, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Jan 26, 17:22:43 GMT-5
주요 통계
이전 종가
$0.0008
시가
$0.0009
일일 범위
$0.0008 - $0.0009
52주 범위
$0.0001 - $0.003
거래량
6.0K
평균 거래량
16.3K
EPS(TTM)
0.07
배당수익률
--
시가총액
$29.9K
AFFY란 무엇인가요?
Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.